Abstract

BackgroundHepatitis delta virus (HDV) and Hepatitis B virus (HBV) co-infection is well known to induce a spectrum of acute and chronic liver diseases which further advance to cirrhosis, fulminant hepatitis and hepatocellular carcinoma (HCC).AimThe aim of the present study was to determine the prevalence of hepatitis D virus super-infection among hepatitis B surface antigen (HBsAg) positive individuals in the highly populated province of Pakistan which is not well known.MethodsSera samples were subjected to HBsAg and anti-HDV screening and finally anti-HDV and HBsAg positive coinfected samples were used for HDV active RNA confirmation using nested polymerase chain reaction (PCR).ResultsOut of total 200 HBsAg positive samples by rapid device, 96 (48%) were also found reactive for HBsAg using enzyme linked immunosorbant assay (ELISA). Out of these HBsAg ELISA positive samples, 80 (88.8%) were anti-HDV ELISA positive which were then subjected to PCR. The amplification results further confirmed 24 (30%) samples to be HDV RNA positive. HDV super-infection was more common in male patients than female patients (81% VS 19%).ConclusionThe current study shows a high prevalence rate of HDV-HBV co-infection in Pakistan that tends to increase over time.

Highlights

  • Hepatitis delta virus (HDV) and Hepatitis B virus (HBV) co-infection is well known to induce a spectrum of acute and chronic liver diseases which further advance to cirrhosis, fulminant hepatitis and hepatocellular carcinoma (HCC)

  • The current study shows a high prevalence rate of HDV-HBV co-infection in Pakistan that tends to increase over time

  • Total 56 anti-HDV enzyme linked immunosorbant assay (ELISA) positive samples were found negative for HDV ribonucleic acid (RNA) by polymerase chain reaction (PCR)

Read more

Summary

Introduction

Hepatitis delta virus (HDV) and Hepatitis B virus (HBV) co-infection is well known to induce a spectrum of acute and chronic liver diseases which further advance to cirrhosis, fulminant hepatitis and hepatocellular carcinoma (HCC). More than 350 million individuals worldwide are Hepatitis B Virus (HBV) carriers and at least 5% of these are co-infected with hepatitis delta virus (HDV) [1]. In association with HBV, HDV produces significantly more severe illness than HBV alone [3]. HDV is well known to induce a spectrum of both acute and chronic liver diseases [4]. Individuals having HBV-HDV co-infection may have more severe acute disease and higher risks of fulminant hepatitis, cirrhosis and hepatocellular carcinoma (HCC) than those having HBV infection alone [5,6]

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.